05/10/2024
4:01 PM | Leap Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/09/2024
11:15 PM | Leap Therapeutics (Filer)
| Form EFFECT | |
04/29/2024
3:34 PM | Leap Therapeutics (Filer)
| Form DEFA14A | |
04/29/2024
3:37 PM | Leap Therapeutics (Filer)
| Form ARS | |
04/25/2024
7:39 PM | Leap Therapeutics (Subject)
Samsara BioCapital, L.P. (Filed by)
| Form SC 13G | |
04/19/2024
3:31 PM | GILEAD SCIENCES, INC. (Reporting)
Leap Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/19/2024
3:31 PM | GILEAD SCIENCES, INC. (Filed by)
Leap Therapeutics (Subject)
| Form SC 13G | |
|
04/11/2024
7:42 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
6:41 AM | Leap Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/18/2024
6:10 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
5:50 AM | Leap Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/31/2024
8:34 PM | LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:34 PM | Leap Therapeutics (Issuer)
Martin Patricia A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:34 PM | Leap Therapeutics (Issuer)
Sirard Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:34 PM | Leap Therapeutics (Issuer)
O'Mahony John Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:35 PM | Leap Therapeutics (Issuer)
Richard Christian M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:35 PM | Baum Jason (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:35 PM | Granfield Christine (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:36 PM | Leap Therapeutics (Issuer)
Schilsky Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:36 PM | Dietz Thomas John (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:37 PM | Leap Therapeutics (Issuer)
Mashiach Nissim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:31 PM | CAVANAUGH JAMES H (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:32 PM | Leap Therapeutics (Issuer)
LI WILLIAM (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:32 PM | Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:33 PM | Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:33 PM | Leap Therapeutics (Issuer)
LOSCALZO JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
7:37 PM | Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
7:38 PM | LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
7:39 PM | Leap Therapeutics (Issuer)
Sirard Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
7:41 PM | Leap Therapeutics (Issuer)
O'Mahony John Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
7:42 PM | Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
4:28 PM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2024
4:10 PM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
6:10 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
5:51 AM | Leap Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/13/2023
1:44 PM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2023
3:30 PM | Leap Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/25/2023
3:30 PM | Leap Therapeutics (Issuer)
LOSCALZO JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:30 PM | Leap Therapeutics (Issuer)
Sirard Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:30 PM | Baum Jason (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:30 PM | Leap Therapeutics (Issuer)
O'Mahony John Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad) The latest flare-up between Israel and Palestinian militants has sent gold prices surging.
Why? Because savvy investors know the endgame of the elites at play…
Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
 See why the elites are pouring billions into gold. |
08/25/2023
3:30 PM | Granfield Christine (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:30 PM | CAVANAUGH JAMES H (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:30 PM | Leap Therapeutics (Issuer)
Schilsky Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:30 PM | Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:31 PM | Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:31 PM | Leap Therapeutics (Issuer)
Richard Christian M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:31 PM | Leap Therapeutics (Issuer)
Mashiach Nissim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:31 PM | LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:31 PM | Leap Therapeutics (Issuer)
Martin Patricia A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:31 PM | Leap Therapeutics (Issuer)
LI WILLIAM (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:31 PM | Dietz Thomas John (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
6:10 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
5:50 AM | Leap Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/12/2023
6:10 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
4:15 PM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2023
4:26 PM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
11:15 PM | Leap Therapeutics (Filer)
| Form EFFECT | |
06/14/2023
3:31 PM | Leap Therapeutics (Filer)
| Form 424B3 | |
05/25/2023
4:18 PM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
6:06 AM | Leap Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2023
5:50 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
